Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Chinese Patent Office
Queensland Health
Chubb
Argus Health
McKesson
US Department of Justice
Colorcon
Moodys

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006008

« Back to Dashboard

NDA 006008 describes MESANTOIN, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the MESANTOIN profile page.

The generic ingredient in MESANTOIN is mephenytoin. Additional details are available on the mephenytoin profile page.
Summary for 006008
Tradename:MESANTOIN
Applicant:Novartis
Ingredient:mephenytoin
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 006008

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKinsey
Julphar
Fuji
Express Scripts
Cantor Fitzgerald
Chinese Patent Office
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.